{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:02:30Z","timestamp":1784829750609,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.juro.2006.09.079","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T07:58:14Z","timestamp":1168502294000},"page":"766-770","source":"Crossref","is-referenced-by-count":15,"title":["Comparative Evaluation of Central Muscarinic Receptor Binding Activity by Oxybutynin, Tolterodine and Darifenacin Used to Treat Overactive Bladder"],"prefix":"10.1097","volume":"177","author":[{"given":"Tomomi","family":"Oki","sequence":"first","affiliation":[{"name":"Department of Pharmacokinetics and Pharmacodynamics and Center of Excellence Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Pharmacodynamics and Center of Excellence Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Pharmacodynamics and Center of Excellence Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Pharmacodynamics and Center of Excellence Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Pharmacodynamics and Center of Excellence Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2006.09.079_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1016\/j.juro.2006.09.079_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine\u2014a new bladder-selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.juro.2006.09.079_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/13543784.13.11.1493","article-title":"Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder","volume":"13","author":"Chapple","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.juro.2006.09.079_bib4","first-page":"314","article-title":"Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier","volume":"6","author":"Pakulski","year":"2000","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.juro.2006.09.079_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinthera.2005.02.014","article-title":"Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly","volume":"27","author":"Scheife","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.juro.2006.09.079_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/00912700122010528","article-title":"Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system","volume":"41","author":"Todorova","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.juro.2006.09.079_bib7","first-page":"125","article-title":"Tissue distribution of tolterodine, a muscarinic receptor antagonist, and transfer into fetus and milk in mice","volume":"51","author":"Pahlman","year":"2001","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.juro.2006.09.079_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1464-410X.2005.05745.x","article-title":"Pharmacodynamic effects of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers","volume":"96","author":"Kay","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2006.09.079_bib9","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1532-5415.2005.00537.x","article-title":"Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients","volume":"53","author":"Kay","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.juro.2006.09.079_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.ju.0000148963.21096.5d","article-title":"Assessment of cognitive function of the elderly population; effects of darifenacin","volume":"173","author":"Lipton","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.09.079_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1368-5031.2005.00585.x","article-title":"Darifenacin in the treatment of overactive bladder","volume":"59","author":"Parsons","year":"2005","journal-title":"Inter J Clin Prac"},{"key":"10.1016\/j.juro.2006.09.079_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4065\/78.6.687","article-title":"Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial","volume":"78","author":"Diokno","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.juro.2006.09.079_bib13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.bjp.0705371","article-title":"In vitro and ex vivo effects of a selective nociceptin\/orphanin FQ (N\/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N\/OFQ and [35S]GTP\u03b3S in rat brain and spinal cord","volume":"139","author":"Yamada","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.juro.2006.09.079_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF00558247","article-title":"The pharmacokinetics of oxybutynin in man","volume":"35","author":"Douchamps","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.juro.2006.09.079_bib15","first-page":"528","article-title":"Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs","volume":"26","author":"Andersson","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.juro.2006.09.079_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0165-0173(96)00009-4","article-title":"Cognitive functions of cortical acetylcholine: toward a unifying hypothesis","volume":"23","author":"Sarter","year":"1997","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.juro.2006.09.079_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-5347(05)00017-0","article-title":"Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder","volume":"175","author":"Maruyama","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.09.079_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00191165","article-title":"Influence of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers","volume":"47","author":"Pietzko","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.juro.2006.09.079_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clinthera.2005.01.006","article-title":"Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly","volume":"27","author":"Kay","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.juro.2006.09.079_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system","volume":"30","author":"Drachman","year":"1974","journal-title":"A relationship to aging? Arch Neurol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534706024621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534706024621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2006.09.079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:06:38Z","timestamp":1784826398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2006.09.079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1016\/j.juro.2006.09.079"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2006.09.079","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}